FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by (90)yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

BACKGROUND: This retrospective analysis is focused on the efficacy and safety of radioimmunotherapy (RIT) with Zevalin(® )in nine patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting after having achieved complete remission or partial remission with FCR. METHO...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pisani, Francesco, Maini, Carlo Ludovico, Sciuto, Rosa, Dessanti, Laura, D'Andrea, Mariella, Assisi, Daniela, Petti, Maria Concetta
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3041690/
https://ncbi.nlm.nih.gov/pubmed/21303501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares